Form4insider filings, from the source

SEC Form 3 · accession 0001209191-16-136466

Protagonist Therapeutics, Inc · PTGX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
William A Hodder
Officer — Sr. VP - Corporate Development
Period of report
Aug 10, 2016
Accepted (ET)
Aug 10, 2016 · 8:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001377121

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———7,943D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1$1.89holding————Mar 26, 2025Common Stock18,052—D
Employee Stock Option (right to buy)F1$1.16holding————Oct 28, 2025Common Stock14,087—D
Employee Stock Option (right to buy)F2$4.21holding————Apr 29, 2026Common Stock21,449—D

Explanation of responses